Professional antigen-presenting cells—monocytes and macrophages—engulf these proteins, digest them into short peptide ...
Phase 2 study to evaluate combination therapy in patients with metastatic colorectal cancer, targeting β-catenin-driven immune exclusion in liver ...
Emerging growth opportunities in the next-generation immune checkpoint inhibitors market include the development of therapies targeting novel immune pathways employed to tackle cancer resistance ...
New research has uncovered immune changes in cancer patients that could help identify which patients are most at risk of dangerous heart complications from cancer drugs, known as immune checkpoint ...
ICIs combined with chemotherapy showed higher efficacy than bevacizumab in treating advanced driver gene–negative NS-NSCLC. The study reported improved PFS and OS for patients receiving ICIs compared ...
A recent study found that monthly prices of checkpoint inhibitors decreased only slightly from 2015 to 2024, with declines in annual average sales prices ranging from 0.21% to 4.85%. "Prices of ...
New research has uncovered immune changes in cancer patients that could help identify which patients are most at risk of dangerous heart complications from cancer drugs, known as immune checkpoint ...
Morning Overview on MSN
The two drugs that just cleared Alzheimer’s plaques in mice already sit in pharmacies as cancer treatments — a shortcut that could reach patients years sooner
In 2012, neuroscientist Gary Landreth and his team at Case Western Reserve University published a finding in Science that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results